Try our Advanced Search for more refined results
Searching dockets in Patient Access Network Foundation x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Racketeer/Corrupt Organization | California Central
Leave to File Document re Discovery Matter
NOTICE OF MOTION AND MOTION for Leave to file Further Supplemental Brief in Support of Motion for Sanctions (ECF No. 231) filed by Defendants Amgen Inc., Chronic Disease Fund, Inc., Onyx Pharmaceuticals, Inc., Onyx Therapeutics, Inc.. (Attachments: # 1 Exhibit A (Proposed Supplemental Brief), # 2 Exhibit B (Declaration of Sean A. Commons), # 3 Exhibit C (Declaration of Christopher M. Assise), # 4 Exhibit 94 to Decl. of C. Assise, # 5 Exhibit 95 to Decl. of C. Assise, # 6 Exhibit 96 to Decl. of C. Assise, # 7 Exhibit 97 to Decl. of C. Assise, # 8 Exhibit 98 to Decl. of C. Assise, # 9 Exhibit 99 to Decl. of C. Assise, # 10 Exhibit 100 to Decl. of C. Assise, # 11 Proposed Order)(Commons, Sean)
Text Only Scheduling Notice
(IN CHAMBERS) ORDER TEXT ONLY ENTRY by Judge Maame Ewusi-Mensah Frimpong: The Court is in receipt of the parties' stipulation to amend a discovery deadline. Dkt. No. 257 . The Stipulation is DENIED WITHOUT PREJUDICE as it is unaccompanied by a detailed declaration containing a highly detailed factual showing of good cause and due diligence, as required by this Court's Civil Standing Order. Should the parties refile the stipulation, they are ordered to file and email a proposed order as an attachment. IT IS SO ORDERED. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (dbe) TEXT ONLY ENTRY
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.